FI963882L - Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina - Google Patents

Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina Download PDF

Info

Publication number
FI963882L
FI963882L FI963882A FI963882A FI963882L FI 963882 L FI963882 L FI 963882L FI 963882 A FI963882 A FI 963882A FI 963882 A FI963882 A FI 963882A FI 963882 L FI963882 L FI 963882L
Authority
FI
Finland
Prior art keywords
inhibitors
benzothiazole derivatives
lipoxygenase
biosynthesis
lipoxygenase biosynthesis
Prior art date
Application number
FI963882A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963882A7 (fi
FI963882A0 (fi
Inventor
James F Eggler
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI963882A7 publication Critical patent/FI963882A7/fi
Publication of FI963882L publication Critical patent/FI963882L/fi
Publication of FI963882A0 publication Critical patent/FI963882A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI963882A 1994-03-28 1995-01-18 Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina FI963882A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21878894A 1994-03-28 1994-03-28
PCT/IB1995/000037 WO1995026346A1 (fr) 1994-03-28 1995-01-18 Derives benzisothiazoles en tant qu'inhibiteurs de la biosynthese de la 5-lipoxygenase

Publications (3)

Publication Number Publication Date
FI963882A7 FI963882A7 (fi) 1996-09-27
FI963882L true FI963882L (fi) 1996-09-27
FI963882A0 FI963882A0 (fi) 1996-09-27

Family

ID=22816518

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963882A FI963882A0 (fi) 1994-03-28 1995-01-18 Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina

Country Status (11)

Country Link
US (1) US5665749A (fr)
EP (1) EP0752990B1 (fr)
JP (1) JP2841120B2 (fr)
AT (1) ATE169298T1 (fr)
CA (1) CA2186513C (fr)
DE (1) DE69503890T2 (fr)
DK (1) DK0752990T3 (fr)
ES (1) ES2119377T3 (fr)
FI (1) FI963882A0 (fr)
GR (1) GR3027598T3 (fr)
WO (1) WO1995026346A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227197B1 (en) * 2000-10-24 2010-10-28 Richter Gedeon Nyrt Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US10500178B2 (en) 2015-03-13 2019-12-10 The Board Of Trustees Of The Leland Stanford Junior University LTB4 inhibition to prevent and treat human lymphedema
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
US5196419A (en) * 1989-02-28 1993-03-23 Imperial Chemical Industries Plc Heterocyclic cyclic ethers
IE911919A1 (en) * 1990-06-21 1992-01-01 Zeneca Ltd Bicyclic heterocyclic compounds
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途

Also Published As

Publication number Publication date
EP0752990B1 (fr) 1998-08-05
FI963882A7 (fi) 1996-09-27
ATE169298T1 (de) 1998-08-15
US5665749A (en) 1997-09-09
GR3027598T3 (en) 1998-11-30
ES2119377T3 (es) 1998-10-01
MX9604429A (es) 1997-07-31
DE69503890T2 (de) 1998-12-10
JP2841120B2 (ja) 1998-12-24
WO1995026346A1 (fr) 1995-10-05
CA2186513C (fr) 1999-03-16
DE69503890D1 (de) 1998-09-10
CA2186513A1 (fr) 1995-10-05
DK0752990T3 (da) 1999-02-08
FI963882A0 (fi) 1996-09-27
JPH09507678A (ja) 1997-08-05
EP0752990A1 (fr) 1997-01-15

Similar Documents

Publication Publication Date Title
FI942423A7 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
FI962800L (fi) Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina
NO20002153D0 (no) Aminotiazol-inhibitorer for cyklin-avhengige kinaser
PL329276A1 (en) Substituted benzenezulphonamide derivatives as prodrugs of cox-2 inhibitors
NO923695D0 (no) Leukotrien-biosyntese-inhibitorer
FI970112A7 (fi) Helico-bakeerin vastaisia atsolonien asyylijohdannaisia
EP1127054A4 (fr) Nouveaux inhibiteurs de l'enzyme impdh
NO20014535D0 (no) Inhibitorer av IMPDH-enzym
NO20022864D0 (no) Aminotiazol inhibitorer av cyclin avhengige kinaser
FI904132A7 (fi) (Kinolin-2-yylimetoksi)Indolit leukotrieenien biosynteesin inhibiittoreina
BR9605309A (pt) Composições de derivados piperazina
PL329639A1 (en) Urea derivatives as inhibitors of impdh enzyme
DE69906311D1 (de) Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren
AU5229800A (en) Migration of different source languages to an executing medium
PL329153A1 (en) Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase
IL114439A0 (en) Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis
BR9508380A (pt) Derivados de azalonas heterocíclicos anti-helicobacter
FI971632A7 (fi) 5-lipoksygenaasin inhibiittoreita
PL333925A1 (en) Method of obtaining derivatives of thiazole
FI931204A7 (fi) Uusia aminobentsosultaamijohdannaisia lipo-oksigenaasin estäjinä
DK0623614T3 (da) 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase
FI963882L (fi) Bentsotiatsolijohdannaiset 5-lipoksigenaasibiosynteesin estoaineina
FI962235L (fi) Uudet bentseenisulfonyyli-imiinijohdannaiset IL-1:n toiminnan inhibiittoreina
ZA948337B (en) Pyrrolidine derivatives inhibitors of leukotriene biosynthesis
NO20001200D0 (no) Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase